Due to its role in amyloid-beta and 24S-OHC production, as well as its possible involvement as a genetic risk factor, the activation of CYP46A1 has the potential to treat Alzheimer’s disease. The gene discussed is CYP46A1; the disease is early-onset autosomal dominant Alzheimer disease.